Eric W. Thomas

Array ( [id] => 4455311 [patent_doc_number] => 07892562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59' [patent_app_type] => utility [patent_app_number] => 12/576055 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10713 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892562.pdf [firstpage_image] =>[orig_patent_app_number] => 12576055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6579739 [patent_doc_number] => 20100273996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Method' [patent_app_type] => utility [patent_app_number] => 12/587236 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 24443 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273996.pdf [firstpage_image] =>[orig_patent_app_number] => 12587236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356231 [patent_doc_number] => 20100086956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'DETECTION OF HIV-RELATED PROTEINS IN URINE' [patent_app_type] => utility [patent_app_number] => 12/572652 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6396 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086956.pdf [firstpage_image] =>[orig_patent_app_number] => 12572652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164942 [patent_doc_number] => 20110195083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'CYCLIC V3 PEPTIDES FOR ANTI HIV-1 VACCINE' [patent_app_type] => utility [patent_app_number] => 13/122972 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34474 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195083.pdf [firstpage_image] =>[orig_patent_app_number] => 13122972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9019926 [patent_doc_number] => 08529909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Method for the production and purification of bovine leukemia virus GP51 surface glycoprotein in the absence of bovine serum' [patent_app_type] => utility [patent_app_number] => 13/059568 [patent_app_country] => US [patent_app_date] => 2009-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 817 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097401 [patent_doc_number] => 20110003735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'PEPTIDE DERIVATIVE FUSION INHIBITORS OF HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/567250 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14191 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003735.pdf [firstpage_image] =>[orig_patent_app_number] => 12567250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606756 [patent_doc_number] => 20100099079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Non-dividing cell-based assay for high throughput antiviral compound screening' [patent_app_type] => utility [patent_app_number] => 12/566074 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11197 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099079.pdf [firstpage_image] =>[orig_patent_app_number] => 12566074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487395 [patent_doc_number] => 20110236373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Method of detecting antibodies and antibody-hiv virion complexes' [patent_app_type] => utility [patent_app_number] => 12/998211 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 14173 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236373.pdf [firstpage_image] =>[orig_patent_app_number] => 12998211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187871 [patent_doc_number] => 20110171250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines' [patent_app_type] => utility [patent_app_number] => 13/063277 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3969 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171250.pdf [firstpage_image] =>[orig_patent_app_number] => 13063277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656480 [patent_doc_number] => 20110305749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'HIV-1 Envelope Polypeptides for HIV Vaccine' [patent_app_type] => utility [patent_app_number] => 13/060564 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 52962 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305749.pdf [firstpage_image] =>[orig_patent_app_number] => 13060564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033051 [patent_doc_number] => 20110082075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Anti-viral fusion peptides' [patent_app_type] => utility [patent_app_number] => 12/583780 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18734 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082075.pdf [firstpage_image] =>[orig_patent_app_number] => 12583780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197140 [patent_doc_number] => 20120121631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'POLYVALENT VACCINE' [patent_app_type] => utility [patent_app_number] => 12/737761 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 109 [patent_no_of_words] => 13262 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12737761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497508 [patent_doc_number] => 07919101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors' [patent_app_type] => utility [patent_app_number] => 12/540325 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 13453 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919101.pdf [firstpage_image] =>[orig_patent_app_number] => 12540325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317602 [patent_doc_number] => 08232379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence' [patent_app_type] => utility [patent_app_number] => 12/508946 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21460 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12508946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490422 [patent_doc_number] => 20090291493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'HUMAN IMMUNODEFICIENCY VIRUS-NEUTRALIZING ANTIBODIES WITH IMPROVED BREADTH AND POTENCY' [patent_app_type] => utility [patent_app_number] => 12/508913 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12828 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291493.pdf [firstpage_image] =>[orig_patent_app_number] => 12508913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277292 [patent_doc_number] => 09493769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Yeast-based assay for measuring the functional activity of an HIV-1 protease in response to an antiviral agent' [patent_app_type] => utility [patent_app_number] => 12/504456 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9023 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 379 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245610 [patent_doc_number] => 20100135994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/504463 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16025 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135994.pdf [firstpage_image] =>[orig_patent_app_number] => 12504463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588704 [patent_doc_number] => 20100061991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Identification of therapeutic agents for HIV infection' [patent_app_type] => utility [patent_app_number] => 12/457673 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15297 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061991.pdf [firstpage_image] =>[orig_patent_app_number] => 12457673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543989 [patent_doc_number] => 20100016225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/478310 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13740 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016225.pdf [firstpage_image] =>[orig_patent_app_number] => 12478310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302864 [patent_doc_number] => 20090297516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'ENGINEERED LECTINS FOR VIRAL INACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/476660 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25819 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297516.pdf [firstpage_image] =>[orig_patent_app_number] => 12476660 [rel_patent_id] =>[rel_patent_doc_number] =>)